{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:39:06Z","timestamp":1760985546319},"reference-count":27,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1536\/ihj.16-109","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T17:08:15Z","timestamp":1484068095000},"page":"63-68","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic Significance of Non-Dilated Left Ventricular Size and Mitral Regurgitation in Patients With Dilated Phase of Hypertrophic Cardiomyopathy"],"prefix":"10.1536","volume":"58","author":[{"given":"Toru","family":"Kubo","sequence":"first","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Tanioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori L.","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-85. (Review)","DOI":"10.1056\/NEJM199703133361107"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Maron BJ, McKenna WJ, Danielson GK, <i>et al<\/i>. American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42: 1687-713. (Review)","DOI":"10.1016\/S0735-1097(03)00941-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kitaoka H, Kubo T, Okawa M, Hitomi N, Furuno T, Doi YL. Left ventricular remodeling of hypertrophic cardiomyopathy: longitudinal observation in a rural community. Circ J 2006; 70: 1543-9.","DOI":"10.1253\/circj.70.1543"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Biagini E, Coccolo F, Ferlito M, <i>et al<\/i>. Dilated-hypokinesis evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatrics and adult patients. J Am Coll Cardiol 2005; 46: 1543-50.","DOI":"10.1016\/j.jacc.2005.04.062"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Thaman R, Gimeno JR, Mutphy RT, <i>et al<\/i>. Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart 2005; 91: 920-5.","DOI":"10.1136\/hrt.2003.031161"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Harris KM, Spirito P, Maron MS, <i>et al<\/i>. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006; 114: 216-25.","DOI":"10.1161\/CIRCULATIONAHA.105.583500"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kubo T, Kitaoka H, Okawa M, <i>et al<\/i>. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese. J Am Coll Cardiol 2005; 46: 1737-43.","DOI":"10.1016\/j.jacc.2005.05.087"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hamada T, Kubo T, Kitaoka H, <i>et al<\/i>. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy. Clin Car-diol 2010; 33: E24-8.","DOI":"10.1002\/clc.20533"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Goto D, Kinugawa S, Hamaguchi S, <i>et al<\/i>. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan. J Cardiol 2013; 61: 65-70.","DOI":"10.1016\/j.jjcc.2012.08.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yoshinaga M, Yoshikawa D, Ishii H, <i>et al<\/i>. Clinical characteristics and long-term outcomes of hypertrophic cardiomyopathy: Results from the Aichi Hypertrophic Cardiomyopathy (AHC) Registry. Int Heart J 2015; 56: 415-20.","DOI":"10.1536\/ihj.14-418"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Maron BJ, Braunwald E. Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease. Circulation 2012; 126: 1640-4.","DOI":"10.1161\/CIRCULATIONAHA.112.123174"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular demodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 2011; 4: 98-108. (Review)","DOI":"10.1016\/j.jcmg.2010.10.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991; 122: 763-71.","DOI":"10.1016\/0002-8703(91)90523-K"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Junker A, Thayssen P, Nielsen B, Andersen PE. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology 1993; 83: 14-20.","DOI":"10.1159\/000175942"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Conti JB, Mills Jr RM. Mitral regurgitation and death while awaiting cardiac transplantation. Am J Cardiol 1993; 71: 617-8.","DOI":"10.1016\/0002-9149(93)90526-I"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002; 144: 524-9.","DOI":"10.1067\/mhj.2002.123575"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kimura A. Molecular genetics and pathogenesis of cardiomyopathy. J Hum Genet 2016; 61: 41-50. (Review)","DOI":"10.1038\/jhg.2015.83"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Iio C, Ogimoto A, Nagai T, <i>et al<\/i>. Association between genetic variation in the SCN10A gene and cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy. Int Heart J 2015; 56: 421-7.","DOI":"10.1536\/ihj.14-411"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-72. (Review)","DOI":"10.1161\/01.CIR.81.4.1161"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Keren A, Billingham ME, Weintraub D, Stinson EB, Popp RL. Mildly dilated cardiomyopathy. Circulation 1985; 72: 302-9.","DOI":"10.1161\/01.CIR.72.2.302"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Keren A, Gottlieb S, Tzivoni D, <i>et al<\/i>. Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. Circulation 1990; 81: 506-17.","DOI":"10.1161\/01.CIR.81.2.506"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gavazzi A, De Maria R, Renosto G, <i>et al<\/i>. The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. SPIC (Italian Multicenter Cardiomyopathy Study) Group. Am Heart J 1993; 125: 410-22.","DOI":"10.1016\/0002-8703(93)90020-A"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kitaoka H, Matsumura Y, Yamasaki N, Kondo F, Furuno T, Doi Y. Long-term prognosis of patients with mildly dilated cardiomyopathy. Circ J 2002; 66: 557-60.","DOI":"10.1253\/circj.66.557"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kubo T, Gimeno JR, Bahl A, <i>et al<\/i>. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol 2007; 49: 2419-26.","DOI":"10.1016\/j.jacc.2007.02.061"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Biagini E, Spirito P, Rocchi G, <i>et al<\/i>. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. Am J Cardiol 2009; 104: 1727-31.","DOI":"10.1016\/j.amjcard.2009.07.057"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Cecchi F, Olivotto I, Maron BJ. Other modes of disability or death including stroke, and treatment strategies, in hypertrophic carciomyopathy. In: Maron BJ, ed. <i>Diagnosis and Management of Hypertrophic Cardiomyopathy.<\/i> Malden, MA: Blackwell Publishing; 2004: 121-31.","DOI":"10.1002\/9780470987469.ch7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wada Y, Aiba T, Matsuyama TA, <i>et al<\/i>. Clinical and pathological impact of tissue fibrosis on lethal arrhythmic events in hypertrophic cardiomyopathy patients with impaired systolic function. Circ J 2015; 79: 1733-41.","DOI":"10.1253\/circj.CJ-15-0104"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/1\/58_16-109\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:51:44Z","timestamp":1498362704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/1\/58_16-109\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-109","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}